Bioproducts company Codexis yesterday filed papers with the SEC to proceed with an initial public offering of its shares.
Credit Suisse Securities and Goldman Sachs will be acting as joint book-running managers, with RBC Capital Markets Corporation and Pacific Crest Securities LLC acting as co-managers for the offering.
Codexis produces what it calls “optimized biocatalysts” (essentially, engineered biochemicals and enzymes) that have applications in process for biofuels, pharmaceuticals, recycling and other industrial processes. The stock offering seeks to raise up to $100 million.